In this article, we review the clinical aspects of imaging with the programmed cell–detecting
protein annexin A5 (anxA5). AnxA5 binds to phosphatidylserine, which is one of the “eat me” …

Objective—Aberrant neutrophil activation occurs during the advanced stages of
atherosclerosis. Once primed, neutrophils can undergo apoptosis or release neutrophil …

To the Editor: Although progressive stenosis of the arterial lumen constitutes the basis for
ischemic symptoms in atherosclerotic vascular disease, acute vascular events are for the …

Objectives: The purpose of this study was to investigate whether the use of a semiautomated
plaque quantification algorithm (reporting volumetric and geometric plaque properties) …

Background Vitamin K-antagonists (VKA) are treatment of choice and standard care for
patients with venous thrombosis and thromboembolic risk. In experimental animal models as …

Abstract Aims Vitamin K antagonists (VKA) are currently the most frequently used drug to
prevent ischaemic stroke in atrial fibrillation (AF) patients. However, VKA use has been …

Objective—This study explored the relationship between coronary atherosclerotic plaque
burden and quantifiable circulating levels of troponin measured with a recently introduced …

Objectives: The purpose of this study was to evaluate interstitial alterations in myocardial
remodeling using a radiolabeled Cy5. 5-RGD imaging peptide (CRIP) that targets …

The unveiling of the heterogeneous nature of cell death modes has compromised the long-
lived consensus that cancer treatment typically kills cancer cells through apoptosis …

Cell death is desirable in cancer cells and undesirable in organs with limited regenerative
potential, like the heart. Cell death comes in many forms, but only apoptosis and to a lesser …